These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 24766902)
1. Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia. Joseph L; Casanegra AI; Dhariwal M; Smith MA; Raju MG; Militello MA; Gomes MP; Gornik HL; Bartholomew JR J Thromb Haemost; 2014 Jul; 12(7):1044-53. PubMed ID: 24766902 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Dang CH; Durkalski VL; Nappi JM Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503 [TBL] [Abstract][Full Text] [Related]
3. Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia. Skrupky LP; Smith JR; Deal EN; Arnold H; Hollands JM; Martinez EJ; Micek ST Pharmacotherapy; 2010 Dec; 30(12):1229-38. PubMed ID: 21114390 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia. Vo QA; Lin JK; Tong LM Ann Pharmacother; 2015 Feb; 49(2):178-84. PubMed ID: 25515865 [TBL] [Abstract][Full Text] [Related]
5. Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia. Bain J; Meyer A Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S104-9. PubMed ID: 26272889 [TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia: treatment options and special considerations. Dager WE; Dougherty JA; Nguyen PH; Militello MA; Smythe MA Pharmacotherapy; 2007 Apr; 27(4):564-87. PubMed ID: 17381384 [TBL] [Abstract][Full Text] [Related]
8. Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia. Lewis BE; Wallis DE; Hursting MJ; Levine RL; Leya F Chest; 2006 Jun; 129(6):1407-16. PubMed ID: 16778256 [TBL] [Abstract][Full Text] [Related]
9. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban. Warkentin TE Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020 [TBL] [Abstract][Full Text] [Related]
10. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia. Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Müller MM; Kropff S; Lindhoff-Last E J Am Coll Cardiol; 2017 Nov; 70(21):2636-2648. PubMed ID: 29169470 [TBL] [Abstract][Full Text] [Related]
11. Bivalirudin for anticoagulation in children. Rayapudi S; Torres A; Deshpande GG; Ross MP; Wohrley JD; Young G; Tarantino MD Pediatr Blood Cancer; 2008 Dec; 51(6):798-801. PubMed ID: 18819124 [TBL] [Abstract][Full Text] [Related]
12. Treatment options for heparin-induced thrombocytopenia. Greinacher A Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978 [TBL] [Abstract][Full Text] [Related]
13. Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review. Wang Y; Zhang K; Yin L; Fu G; Liu Z Ann Vasc Surg; 2022 Mar; 80():392.e1-392.e7. PubMed ID: 34656708 [TBL] [Abstract][Full Text] [Related]
14. Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: comparison of clinical outcomes. Abel EE; Kane-Gill SL; Seybert AL; Kellum JA Am J Health Syst Pharm; 2012 Sep; 69(18):1559-67. PubMed ID: 22935938 [TBL] [Abstract][Full Text] [Related]
15. Successful use of a bivalirudin treatment protocol to prevent extracorporeal thrombosis in ambulatory hemodialysis patients with heparin-induced thrombocytopenia. Al-Ali FS; Elsayed M; Khalifa S; Abdulla AE; Tolba H; Bouanane H; Ibrahim R; Hamad A Hemodial Int; 2016 Apr; 20(2):204-7. PubMed ID: 26501237 [TBL] [Abstract][Full Text] [Related]
16. Argatroban Versus Bivalirudin in the Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia. Duewell BE; Briski MJ; Feih JT; Rinka JRG; Tawil JN J Pharm Pract; 2021 Aug; 34(4):529-534. PubMed ID: 31645190 [TBL] [Abstract][Full Text] [Related]
17. Bivalirudin use during radiofrequency catheter ablation procedures in two patients with a history of heparin-induced thrombocytopenia. Baetz BE; Gerstenfeld EP; Kolansky DM; Spinler SA Pharmacotherapy; 2010 Sep; 30(9):952. PubMed ID: 20812431 [TBL] [Abstract][Full Text] [Related]
18. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study. Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of anticoagulation with bivalirudin for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation. Hanna DJ; Torbic H; Militello M; Strnad K; Krishnan S; Hohlfelder B Int J Artif Organs; 2022 Aug; 45(8):688-694. PubMed ID: 35708334 [TBL] [Abstract][Full Text] [Related]
20. Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia. Tsu LV; Dager WE Ann Pharmacother; 2011 Oct; 45(10):1185-92. PubMed ID: 21881032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]